What is andropause? Dr Sanjay Prakash J talks about the not-so-talked-about topic. Don't mistake it for normal ageing or stress.
Marius Pharmaceuticals, Inc. a patient-centric healthcare company committed to advancing innovative therapies for testosterone deficiency, today announced that Health Canada has approved KYZATREX ® ...
6don MSN
40% boost in survival for men: Pairing two cancer drugs may reduce prostate cancer death risk
A groundbreaking study reveals that combining two drugs significantly boosts survival for men with high-risk, recurring ...
“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...
Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy.
A prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, ...
Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new study says ...
News-Medical.Net on MSN
Study identifies thyroid hormone pathway as key player in prostate cancer development
A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new ...
News-Medical.Net on MSN
Age impacts systemic therapy outcomes in metastatic prostate cancer
Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new study says ...
SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.
Genomic profiling revealed druggable targets in 39% of advanced prostate cancer cases, guiding personalised treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback